durvalumab

Ukraine

Drugs containing this active substance

  • IMFINZI

    The drug is prescribed for the treatment of adult patients with non-small cell lung cancer (either in combination with chemotherapy or after surgery or in unresectable cases), small cell lung cancer (as first-line therapy in combination with chemotherapy), as well as biliary tract cancer (in combination with gemcitabine and cisplatin).

    Form: concentrate for infusion solution

    Active substance Dosage
    durvalumab 50 mg/ml

    ATC: L01FF03

    Manufacturer: AstraZeneca Pharmaceuticals LP (quality control (excluding sterility and endotoxin))